instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Fatigue'? | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | Recovering | ReactionOutcome | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
What was the outcome of reaction 'Immune-mediated myositis'? | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | Recovering | ReactionOutcome | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
What was the outcome of reaction 'Myasthenia gravis'? | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | Recovering | ReactionOutcome | CC BY-NC-ND | 34026125 | 19,496,474 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | PEMBROLIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34026127 | 19,971,614 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | PEMBROLIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34026127 | 19,922,158 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Non-small cell lung cancer metastatic'. | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | PEMBROLIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34026127 | 19,922,158 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | PEMBROLIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34026127 | 19,922,158 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | PEMBROLIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34026127 | 19,971,614 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash maculo-papular'. | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | PEMBROLIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34026127 | 19,971,614 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic response delayed'. | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | PEMBROLIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34026127 | 19,971,614 | 2021-05 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34026127 | 19,971,614 | 2021-05 |
What was the outcome of reaction 'Pruritus'? | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | Recovered | ReactionOutcome | CC BY-NC | 34026127 | 19,971,614 | 2021-05 |
What was the outcome of reaction 'Rash maculo-papular'? | Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report.
We report the case of a patient with a complete metastatic adrenal response on Pembrolizumab for metastatic lung cancer. Treatment with a systemic corticosteroid-induced a time-dependent progression at his metastatic... | Not recovered | ReactionOutcome | CC BY-NC | 34026127 | 19,971,614 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abscess neck'. | Hemorrhage and secondary infection of an infantile hemangioma during involution: A case report.
Bleeding complications due to IHs are generally limited. Secondary abscess formation after hemorrhage has not been reported. Rapid expansion of an IH should raise concern for hemorrhage in IHs that have been an involutionary... | PROPRANOLOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 34026128 | 19,807,349 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Hemorrhage and secondary infection of an infantile hemangioma during involution: A case report.
Bleeding complications due to IHs are generally limited. Secondary abscess formation after hemorrhage has not been reported. Rapid expansion of an IH should raise concern for hemorrhage in IHs that have been an involutionary... | PROPRANOLOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 34026128 | 19,807,349 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Hemorrhage and secondary infection of an infantile hemangioma during involution: A case report.
Bleeding complications due to IHs are generally limited. Secondary abscess formation after hemorrhage has not been reported. Rapid expansion of an IH should raise concern for hemorrhage in IHs that have been an involutionary... | PROPRANOLOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 34026128 | 19,807,349 | 2021-05 |
What was the dosage of drug 'PROPRANOLOL HYDROCHLORIDE'? | Hemorrhage and secondary infection of an infantile hemangioma during involution: A case report.
Bleeding complications due to IHs are generally limited. Secondary abscess formation after hemorrhage has not been reported. Rapid expansion of an IH should raise concern for hemorrhage in IHs that have been an involutionary... | 2 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 34026128 | 19,807,349 | 2021-05 |
What was the outcome of reaction 'Haemorrhage'? | Hemorrhage and secondary infection of an infantile hemangioma during involution: A case report.
Bleeding complications due to IHs are generally limited. Secondary abscess formation after hemorrhage has not been reported. Rapid expansion of an IH should raise concern for hemorrhage in IHs that have been an involutionary... | Recovered | ReactionOutcome | CC BY | 34026128 | 19,807,349 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatinine increased'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac murmur'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'International normalised ratio increased'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oliguria'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Swelling'. | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | WARFARIN | DrugsGivenReaction | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Acute kidney injury'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Blood creatinine increased'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Cardiac murmur'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Haematuria'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'International normalised ratio increased'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Nephropathy'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Oedema peripheral'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Oliguria'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Renal impairment'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
What was the outcome of reaction 'Swelling'? | Warfarin-related nephropathy: A case report of a delayed renal function improvement.
We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.
1 BAC... | Recovering | ReactionOutcome | CC BY | 34026147 | 19,460,053 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardio-respiratory arrest'. | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | EPINEPHRINE, HYDROCORTISONE, ONDANSETRON HYDROCHLORIDE, PHENIRAMINE | DrugsGivenReaction | CC BY | 34026152 | 19,295,174 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | EPINEPHRINE, ONDANSETRON, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34026152 | 19,421,769 | 2021-05 |
What was the administration route of drug 'EPINEPHRINE'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Intramuscular | DrugAdministrationRoute | CC BY | 34026152 | 19,295,174 | 2021-05 |
What was the administration route of drug 'HYDROCORTISONE'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34026152 | 19,295,174 | 2021-05 |
What was the administration route of drug 'ONDANSETRON HYDROCHLORIDE'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34026152 | 19,295,174 | 2021-05 |
What was the administration route of drug 'ONDANSETRON'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34026152 | 19,421,769 | 2021-05 |
What was the administration route of drug 'PHENIRAMINE'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34026152 | 19,295,174 | 2021-05 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34026152 | 19,421,769 | 2021-05 |
What was the dosage of drug 'ONDANSETRON'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | 4 mg (milligrams). | DrugDosage | CC BY | 34026152 | 19,421,769 | 2021-05 |
What was the outcome of reaction 'Cardio-respiratory arrest'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Fatal | ReactionOutcome | CC BY | 34026152 | 19,295,174 | 2021-05 |
What was the outcome of reaction 'Drug ineffective'? | Fatal anaphylaxis to intravenous ondansetron: A case report.
The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.
1 INTRODUCTION... | Fatal | ReactionOutcome | CC BY | 34026152 | 19,421,769 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedematous pancreatitis'. | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | ARSENIC, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 34026155 | 19,389,392 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis acute'. | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | ARSENIC TRIOXIDE, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 34026155 | 19,377,091 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis'. | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | ARSENIC TRIOXIDE, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-ND | 34026155 | 19,994,521 | 2021-05 |
What is the weight of the patient? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | 103 kg. | Weight | CC BY-NC-ND | 34026155 | 19,389,392 | 2021-05 |
What was the administration route of drug 'ARSENIC TRIOXIDE'? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34026155 | 19,994,521 | 2021-05 |
What was the administration route of drug 'ARSENIC'? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34026155 | 19,389,392 | 2021-05 |
What was the administration route of drug 'DEXAMETHASONE'? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34026155 | 19,994,521 | 2021-05 |
What was the administration route of drug 'TRETINOIN'? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34026155 | 19,389,392 | 2021-05 |
What was the dosage of drug 'ARSENIC'? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | ARSENIC WAS DOSE REDUCED BY 50% TO 0.075 MG/KG ABW | DrugDosageText | CC BY-NC-ND | 34026155 | 19,389,392 | 2021-05 |
What was the outcome of reaction 'Oedematous pancreatitis'? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | Recovered | ReactionOutcome | CC BY-NC-ND | 34026155 | 19,389,392 | 2021-05 |
What was the outcome of reaction 'Pancreatitis acute'? | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and ac... | Recovered | ReactionOutcome | CC BY-NC-ND | 34026155 | 19,377,091 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspartate aminotransferase increased'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood bilirubin increased'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatinine increased'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood urea increased'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomegaly'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, UNSPECIFIED INGREDIENT, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,489,068 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | AZOSEMIDE, CARBOPLATIN, CARVEDILOL, CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOBUTAMINE HYDROCHLORIDE, ENALAPRIL, EPLERENONE, ETOPOSIDE, IFOSFAMIDE, IVABRADINE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, TOLVAPTAN, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,485,390 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mitral valve incompetence'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | AZOSEMIDE, CARBOPLATIN, CARVEDILOL, CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOBUTAMINE HYDROCHLORIDE, ENALAPRIL, EPLERENONE, ETOPOSIDE, IFOSFAMIDE, IVABRADINE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, TOLVAPTAN, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,485,390 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 34026170 | 19,469,599 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus tachycardia'. | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, PIRARUBICIN, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34026170 | 19,494,454 | 2021-05 |
What is the weight of the patient? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | 55 kg. | Weight | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'CARBOPLATIN'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'DEXAMETHASONE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'ETOPOSIDE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'IFOSFAMIDE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'IVABRADINE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Oral | DrugAdministrationRoute | CC BY | 34026170 | 19,477,397 | 2021-05 |
What was the administration route of drug 'PIRARUBICIN'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'PREDNISOLONE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'RITUXIMAB'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the administration route of drug 'VINCRISTINE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Intravenous drip | DrugAdministrationRoute | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the dosage of drug 'AZOSEMIDE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | 30 mg (milligrams). | DrugDosage | CC BY | 34026170 | 19,477,397 | 2021-05 |
What was the dosage of drug 'EPLERENONE'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | 25 mg (milligrams). | DrugDosage | CC BY | 34026170 | 19,477,397 | 2021-05 |
What was the dosage of drug 'TOLVAPTAN'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | 7.5 mg (milligrams). | DrugDosage | CC BY | 34026170 | 19,477,397 | 2021-05 |
What was the dosage of drug 'UNSPECIFIED INGREDIENT'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | TOTAL 400 MILLIGRAM/M^2 | DrugDosageText | CC BY | 34026170 | 19,489,068 | 2021-05 |
What was the outcome of reaction 'Alanine aminotransferase increased'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Aspartate aminotransferase increased'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Blood bilirubin increased'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Blood creatinine increased'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Blood pressure systolic decreased'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovered | ReactionOutcome | CC BY | 34026170 | 19,477,397 | 2021-05 |
What was the outcome of reaction 'Blood urea increased'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Cardiac failure'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Cardiomegaly'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Haemodynamic instability'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovered | ReactionOutcome | CC BY | 34026170 | 19,477,397 | 2021-05 |
What was the outcome of reaction 'Mitral valve incompetence'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Pleural effusion'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovering | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
What was the outcome of reaction 'Sinus tachycardia'? | Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorabl... | Recovered | ReactionOutcome | CC BY | 34026170 | 19,494,454 | 2021-05 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.